CD95 ligand-induced apoptosis of human medulloblastoma cells
M Weller1, M Schuster, T Pietsch
1Department of Neurology, University of Tübingen, Medical School, Germany. michael.weller@uni-tuebingen.de
Abstract:
CD95 ligand (CD95L) is a cytotoxic cytokine that induces apoptosis in susceptible target cells. Medulloblastoma is the most common non-glial intrinsic malignancy of the brain. In this study, we have studied CD95-mediated apoptosis of human medulloblastoma cell lines. We found that DAOY, MED-1 and D-283 cells are susceptible to CD95L-induced apoptosis when RNA and protein synthesis are inhibited. Preexposure of D-283, but not DAOY or MED-1 cells, to interferon-gamma or tumor necrosis factor-alpha enhances CD95 expression and primes these cells for CD95-mediated apoptosis. Inhibitors of interleukin 1-converting enzyme (ICE)-like protease (caspase) activity block CD95L-induced cytotoxicity, suggesting that caspases mediate the death signal induced by CD95L in human medulloblastoma cells. Interestingly, medulloblastoma cells belong to an increasing number of tumor cell types that coexpress CD95 and CD95L. We conclude that CD95 may be a promising target of immunochemotherapy for human medulloblastoma.
Insights
CD95 ligand (CD95L) induces apoptosis in medulloblastoma cells, particularly when combined with interferon-gamma or tumor necrosis factor-alpha. Caspase activity mediates this CD95L-induced cell death, suggesting CD95 as a potential immunochemotherapy target.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Medulloblastoma is the most common pediatric brain tumor.
- CD95 ligand (CD95L) is a cytotoxic cytokine inducing apoptosis.
- CD95-mediated apoptosis plays a role in cancer cell death.
Purpose of the Study:
- To investigate CD95-mediated apoptosis in human medulloblastoma cell lines.
- To determine the role of CD95L in medulloblastoma cell death.
- To explore CD95 as a potential therapeutic target.
Main Methods:
- Treatment of medulloblastoma cell lines (DAOY, MED-1, D-283) with CD95L.
- Inhibition of RNA and protein synthesis.
- Preexposure to interferon-gamma (IFN-γ) or tumor necrosis factor-alpha (TNF-α).
- Assessment of CD95 expression and apoptosis induction.
- Use of caspase inhibitors to block cytotoxicity.
Main Results:
- DAOY, MED-1, and D-283 cells showed susceptibility to CD95L-induced apoptosis with inhibited synthesis.
- Preexposure to IFN-γ or TNF-α enhanced CD95 expression and primed D-283 cells for apoptosis.
- Caspase inhibitors blocked CD95L-induced cytotoxicity, indicating caspase-mediated death signaling.
- Medulloblastoma cells coexpressed CD95 and CD95L.
Conclusions:
- CD95-mediated apoptosis is a viable mechanism for inducing death in medulloblastoma cells.
- Combination therapy involving CD95 modulation may enhance treatment efficacy.
- CD95 represents a promising target for medulloblastoma immunochemotherapy.
More Related Videos
Related Concept Videos
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy


